Emery Pharma Stability Studies | ICH & FDA Expiration Testing & Impurity Profiling @Emerypharma
Emery Pharma Stability Studies | ICH & FDA Expiration Testing & Impurity Profiling  @Emerypharma
Uploaded August 2025 | Updated September 2026, 2 weeks ago
Emery Pharma is your trusted partner for both regulated (GLP/GMP) and non-regulated stability studies. Our ICH-compliant stability chambers offer a full range of temperature and humidity conditions for accelerated, intermediate, and long-term testing. With deep expertise in analytical method development, validation, and stability-indicating methods using LC-MS/MS, HPLC, GC-MS, and more, we ensure accurate, reliable, and audit-ready data. We handle small molecules, biologics, APIs, and finished products with the highest quality standards, supported by FDA inspection readiness and rigorous QA oversight. Whether you need rapid turnaround for R&D decisions or long-term stability programs for regulatory submissions, our team delivers precision, compliance, and scientific excellence—helping you meet timelines and maintain product integrity from development through commercialization.

About Emery Pharma:
Emery Pharma is deeply committed to advancing public health and exclusively focuses on projects that enhance the well-being of both individuals and the environment. As a comprehensive contract research laboratory, Emery Pharma provides extensive support across the entire spectrum of pharmaceutical development, covering small molecule drugs, biologics, biosimilars, gene therapy, botanicals, and more.

Emery Pharma's array of premium services includes analytical and bioanalytical solutions, microbiology and cell biology services, drug and impurity characterization, and comprehensive R&D with cGMP/GLP support. The Emery Pharma team excels in customizing innovative solutions tailored to the unique requirements of each client. They seamlessly oversee the entire process, from initial drug discovery to thorough data analysis and insights generation. Their expertise allows them to tackle scientific challenges proactively, ensuring clients avoid unnecessary setbacks.

Emery Pharma's accomplished chemists and biologists harness state-of-the-art technology, encompassing cutting-edge tools such as high-resolution mass spectrometry (Orbitrap), triple quad LC-MS/MS, GC-MS, preparative HPLC, and 400 MHz multinuclear NMR.

For further details, please don't hesitate to reach out to Emery Pharma at info@emerypharma.com or explore their website at:
emerypharma.com
Emery Pharma Stability Studies | ICH & FDA Expiration Testing & Impurity ProfilingBill Wilson, MD: The 22 Symptoms of CARB Syndrome and How GLP-1 May Help Patients RecoverPresentation at Exelixis: Nitrosamine Impurities – Valsartan, Zantac & FDA 2025 Deadline InsightsAre Governments Playing Roulette with Nuclear Weapons, Professor Ivana Hughes?  #nuclearwarningRobert Lustig:Sugar Is a Mitochondrial Toxin-Fructose, Making Up 50%, Is the Key Culprit #fattyliverBill Wilson, MD: Feeling depressed with a bigger appetite? It may be CARB syndromeBreakthrough Neoliposomal Drug Delivery Platform Transforming Oncology and Hormone Therapy #cancerEmery Pharma Antimicrobial Testing | MIC, MBC, MFC, MBEC & Resistance Profiling ExpertsRobert Lustig: Fructose’s Hidden Dangers—How It Mimics Reye’s Syndrome in the LiverRobert Lustig: Lipodystrophy and Insulin Resistance—When Too Little Fat Becomes a Problem #doctorsAntibody Drug Conjugates (ADCs) – Revolutionizing Cancer Treatment #cancer #cancertreatmentsBill Wilson, MD: GIPs and GLP-1s Are Transforming Metabolic Health and CARB Syndrome Treatment
Emery Pharma |

Emery Pharma Stability Studies | ICH & FDA Expiration Testing & Impurity Profiling

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER